Nuveen Asset Management, LLC Inhibrx, Inc. Transaction History

Nuveen Asset Management, LLC

$329 Billion
Q1 2024

A detailed history of Nuveen Asset Management, LLC transactions in Inhibrx, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 82,829 shares of INBX stock, worth $1.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

82,829

Previous 84,011 1.41%

Holding current value

$1.17 Million

Previous $3.19 Million 9.3%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$32.76 - $39.56 $38,722 - $46,759	-1,182 Reduced 1.41%	82,829 $2.9 Million
Q4 2023 Feb 14, 2024	SELL	$14.5 - $38.0 $76,154 - $199,576	-5,252 Reduced 5.88%	84,011 $3.19 Million
Q3 2023 Nov 14, 2023	SELL	$15.75 - $26.31 $4,315 - $7,208	-274 Reduced 0.31%	89,263 $1.64 Million
Q2 2023 Aug 14, 2023	BUY	$16.96 - $27.82 $14,297 - $23,452	843 Added 0.95%	89,537 $2.32 Million
Q1 2023 May 15, 2023	BUY	$18.45 - $27.14 $738 - $1,085	40 Added 0.05%	88,694 $1.67 Million

Q4 2022 Feb 14, 2023	SELL	$20.18 - $33.33 $529,967 - $875,312	-26,262 Reduced 22.85%	88,654 $2.19 Million
Q3 2022 Nov 14, 2022	SELL	$11.58 - $24.73 $5,685 - $12,142	-491 Reduced 0.43%	114,916 $2.06 Million
Q2 2022 Aug 15, 2022	BUY	$8.52 - $25.26 $275,945 - $818,120	32,388 Added 39.01%	115,407 $1.31 Million
Q1 2022 May 16, 2022	BUY	$19.89 - $43.18 $20,267 - $44,000	1,019 Added 1.24%	83,019 $1.9 Million
Q4 2021 Feb 14, 2022	SELL	$26.75 - $46.02 $178,583 - $307,229	-6,676 Reduced 7.53%	82,000 $3.13 Million
Q3 2021 Nov 12, 2021	SELL	$25.18 - $37.81 $199,022 - $298,850	-7,904 Reduced 8.18%	88,676 $3.28 Million
Q2 2021 Aug 16, 2021	BUY	$14.69 - $27.52 $983,642 - $1.84 Million	66,960 Added 226.06%	96,580 $2.66 Million
Q1 2021 May 17, 2021	SELL	$16.27 - $41.26 $52,031 - $131,949	-3,198 Reduced 9.74%	29,620 $595,000
Q4 2020 Feb 16, 2021	BUY	$15.96 - $50.0 $523,775 - $1.64 Million	32,818 New	32,818 $1.08 Million

Others Institutions Holding INBX

# of Institutions

132

Shares Held

35.5M

Call Options Held

64.8K

Put Options Held

91.3K

View Full List

About Inhibrx, Inc.

Ticker INBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,057,700
Market Cap $553M
Description
Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...

More about INBX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Inhibrx, Inc. Transaction History